From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 526,999 shares, representing 3.08% for $7.52 million under the buyback announced on March 14, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.49 USD | -2.96% | -0.89% | -26.45% |
Apr. 29 | OptimizeRx Corporation Provides Earnings Guidance for the First Quarter of 2024 | CI |
Apr. 16 | Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.45% | 197M | |
+28.81% | 441B | |
+26.15% | 263B | |
+6.68% | 140B | |
+7.84% | 92.89B | |
+28.40% | 90.53B | |
+53.89% | 58.64B | |
+17.61% | 46.96B | |
+1.72% | 36.7B | |
+20.56% | 36.11B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- Tranche Update on OptimizeRx Corporation's Equity Buyback Plan announced on March 14, 2023.